Latest News- Point Of Care (POC) Haematology Diagnostics Market: Consumables is expected to lead the Product segment during 2024-2028

The Point Of Care (POC) Haematology Diagnostics Market is being driven by Increasing prevalence of blood disorders and infectious disease

The Point Of Care (POC) Haematology Diagnostics Market is expected to grow at a CAGR of 12.55% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 4676 million. In the POC Haematology Diagnostics Market, online marketing platforms, such as CLIA waived and eBay, have become increasingly popular among companies due to their cost-effective benefits. Mid-sized and small-scale businesses can minimize operational costs by eliminating the need for physical sales offices, hiring sales forces, and managing distribution channels. Notable companies like Abbott and Sysmex are capitalizing on this trend, focusing on online sales to meet the escalating demand for POC hematology diagnostics. Online purchasing offers numerous advantages to customers, including convenience, seamless payment processing, discounts, and the ability to compare various product offerings efficiently. 

Get more information on Point Of Care (POC) Haematology Diagnostics Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Consumables
  • Systems
• End-user
  • Hospitals and clinics
  • Homecare settings
  • Clinical diagnostic laboratories
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
  • Asia
    • China
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing prevalence of blood disorders and infectious disease
• Increasing growth in POC hematology diagnostics product launches
• Paradigm shift from benchtop to portable hematology diagnostic systems

However, the market also witnesses some limitations, which are as follows:

• High cost of hematology diagnostic products
• Efficacy issues of POC hematology diagnostics products
• Product recalls due to stringent regulations

Benefits of Buying Global Point Of Care (POC) Haematology Diagnostics Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Point Of Care (POC) Haematology Diagnostics Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Point of Care (POC) Haematology Diagnostics Market encompasses various technologies such as Lateral Flow Assays, Dipsticks, Microfluidics, Immunoassays, Molecular Diagnostics, Prescription-Based Testing, and Over-the-Counter (OTC) Testing. These technologies find applications in diverse sectors including Home Care, Professional Diagnostic Centers, Research Laboratories, and Emergency departments (ED). Glucose testing is a common application, but POC diagnostics also play a crucial role in infectious disease diagnosis and monitoring for conditions like HIV, Hepatitis C, Malarial parasites, Dengue, Ebola, and Zika viruses. ED technicians (EDTs) utilize these tools for quality process and disease diagnosis in emergency settings, contributing significantly to improved health outcomes. Biosensors and advanced technologies like Immunoassays and Molecular Diagnostics further enhance the capabilities of POC Haematology Diagnostics in detecting pathogens and human immunodeficiency virus, human papillomavirus, and other infectious diseases.

Market Research Overview

The Point of Care (POC) Haematology Diagnostics Market is a significant segment of the global healthcare equipment market, encompassing Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Prescription-Based Testing, Over-the-Counter (OTC) Testing, and Professional Diagnostic Centers. According to Technavio, the global healthcare equipment market, which covers manufacturers of diagnostic equipment and devices, is sized based on the combined revenue generated across various therapy areas. This market consists of the Devices segment, which includes advanced, differentiated, and clinically tested data-driven devices. The POC Haematology Diagnostics Market specifically focuses on haematology tests performed at or near the patient's point of care, offering rapid, accurate results for timely diagnosis and treatment.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/